Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Carly J. King, Josha Woodward, Jacob Schwartzman, Daniel J. Coleman, Robert Lisac, Nicholas J. Wang, Kathryn Van Hook, Lina Gao, Joshua Urrutia, Mark A. Dane, Laura M. Heiser, Joshi J. Alumkal
Published Nov 20, 2017 · Vol. 8, No. 67 · pp. 111084-111095
Eva Obermayr, Natalia Bednarz-Knoll, Beatrice Orsetti, Heinz-Ulrich Weier, Sandrina Lambrechts, Dan Cacsire Castillo-Tong, Alexander Reinthaller, Elena Ioana Braicu, Sven Mahner, Jalid Sehouli, Ignace Vergote, Charles Theillet, Robert Zeillinger, Burkhard Brandt
Published Nov 16, 2017 · Vol. 8, No. 63 · pp. 106415-106428
Dominik Paul Modest, Sebastian Stintzing, Ludwig Fischer von Weikersthal, Thomas Decker, Alexander Kiani, Ursula Vehling-Kaiser, Salah-Eddin Al-Batran, Tobias Heintges, Christoph Kahl, Gernot Seipelt, Frank Kullmann, Werner Scheithauer, Markus Moehler, Julian Walter Holch, Jobst von Einem, Swantje Held, Volker Heinemann
Published Nov 11, 2017 · Vol. 8, No. 62 · pp. 105749-105760